The Nanochannel Delivery System for Constant Testosterone Replacement Therapy

ConclusionsIn conclusion, we demonstrate that nDS‐F1 implants represents a novel approach for the treatment of male hypogonadism. Further studies will be performed in view of translating the technology to clinical use. Ferrati S, Nicolov E, Zabre E, Geninatti T, Shirkey BA, Hudson L, Hosali S, Crawley M, Khera M, Palapattu G, and Grattoni A. The nanochannel delivery system for constant testosterone replacement therapy. J Sex Med **;**:**–**.

Source: The Journal of Sexual Medicine - April 30, 2015 Category: Sexual Medicine Authors: Silvia Ferrati, Eugenia Nicolov, Erika Zabre, Thomas Geninatti, Beverly A. Shirkey, Lee Hudson, Sharath Hosali, Michael Crawley, Mohit Khera, Ganesh Palapattu, Alessandro Grattoni Tags: Report Source Type: research